Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

Reagents are expected to dominate with 27.2% market share in 2025, thanks to their essential role in protein expression ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The medium, which is designed for high density perfusion culture, is available in a variety of media package options for continuous processing.

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Cell Engineering Technology Will Increase Recombinant Protein Production for Food Ingredients, Industrial Enzymes, and Other ...

The conducting airways are the primary target for gene transfer in cystic fibrosis (CF), yet the inflammation associated with CF lung disease could potentially pose a significant barrier to gene ...

A clinical review of a novel blood test use in rural Alabama for multi-cancer detection, analyzing methylation patterns of cell-free DNA and future strategies. This is an ASCO Meeting Abstract from ...

The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...